NCT02976259View on ClinicalTrials.gov

Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HIV Infection

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

HIV Infection Primary

Interventions

DRUG

Dolutegravir

All patients included must have treated by dolutegravir. They will have some exams (plasma samples, sperm samples)

All Listed Sponsors

lead

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba

OTHER

NCT02976259 - Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HIV Infection | Biotech Hunter | Biotech Hunter